The Latest Breaking News from NYSE

Cigna Group (NYSE:CI) reported second-quarter 2025 revenue of $67.13 billion on Thursday, beating analyst estimates of $62.46 billion.

California's $21 billion wildfire insurance fund, created to protect ratepayers and keep investor-owned utilities solvent, could be on the verge of depletion if Southern California Edison, which is owned by Edison International (NYSE:EIX), is found liable for the devastating Eaton Fire in early 2025.

U.S. stocks inched higher midday Wednesday, as investors digested upbeat economic data while keeping an optimistic tone ahead of the Federal Reserve's policy decision and a wave of key tech earnings due after the bell.

Amazon.com (NASDAQ:AMZN) has agreed to pay The New York Times (NYSE:NYT) between $20 million and $25 million annually under a multiyear content licensing deal, according to people familiar with the terms.

Fidelity National Information Services Inc. (NYSE:FIS) has teamed up with Circle Internet Group Inc. (NYSE:CRCL) to facilitate the use of stablecoins by financial institutions.

Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK) has been quietly amassing a staggering $4.37 billion in annual dividend income, translating to a whopping $138.63 every second, without selling a single share.

Deckers Outdoor Corporation (NYSE:DECK) is trading sideways on Tuesday. The stock opened higher on Friday after beating earning's estimates. But a selloff followed.

Bausch Health Companies Inc. (NYSE:BHC) on Tuesday agreed to indirectly acquire DURECT Corp (NASDAQ:DRRX), including a novel therapeutic molecule, larsucosterol.

Investor Kevin O’Leary, better known as “Mr. Wonderful” from the “Shark Tank” TV show, believes the U.S. market is stabilizing despite recent trade tensions because President Donald Trump has figured out a workaround on tariffs.

The ‘Oracle of Omaha’ — Warren Buffett is not invested in any pure-play artificial intelligence (AI) companies, but he holds these five stocks via Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK), which leverage AI in their businesses on scale.

The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted access.